Olympus Corporations’ Odin Medical receives US FDA clearance for first cloud-based AI endoscopy system for colonoscopy
Posted:
Odin Medical, an Olympus Corporation company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the first cloud-based AI technology designed to assist gastroenterologists in detecting suspected colorectal polyps during colonoscopy procedures, the CADDIE computer-aided detection (CADe) device.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us